Babafemi Taiwo, MBBS
Gene Stollerman Professor of Medicine and Chief
Division of Infectious Diseases at Northwestern University, Chicago
- Describe the rationale for HIV treatment in all PLWH.
- Describe the principles of ART initiation including laboratory evaluation and drug classes.
- Review emerging concepts such as rapid ART initiation and two-drug ART.
Babafemi Taiwo, MBBS is a Professor of Medicine at Northwestern University. He received his MBBS from Nigeria’s University of Ibadan College of Medicine, he trained at the University of Massachusetts Berkshire Medical Center. Dr. Taiwo went on to complete subspecialty training in Infectious Diseases at Northwestern University Feinberg School of Medicine before joining the faculty. He won the John Carey Young Investigator Award in 2009 in recognition of his contributions to research on HIV resistance and management of co-infections. His expertise in novel therapies and the implementation of clinical research in resource-limited settings serve a critical function in ACTG leadership. As chair of multiple ACTG protocols and committees, he has contributed to important advancements in HIV research and clinical care.
The enduring material is jointly provided by Beaumont Health, American Academy of CME, Inc., and the American Conference for the Treatment of HIV (ACTHIV).
The 13th Annual American Conference for the Treatment of HIV (ACTHIV) was held April 11-13, 2019 in Miama, FL. The Conference was supported by the Clinical Education Initiative, New York State Department of Health, AIDS Institute. The conference and this web archive were supported by educational grants from Gilead Sciences; Janssen Therapeutics, Division of Janssen Products, LP; Merck & Co., and ViiV HealthCare.
Hardware/Software Requirements To access this activity hardware and software requirements are noted below.
Windows Requirements: • Operating system: Windows XP Service Pack 2 or later • Browser: Internet Explorer 7 or later, Mozilla Firefox 2.5 or later • Internet connection: DSL, cable modem, or other high-speed connection • Flash: Adobe Flash Player 9 or later
Macintosh Requirements: • Operating system: Mac OS X v10.3 or later • Browser: Mozilla Firefox 2.5 or later • Internet connection: DSL, cable modem, or other high-speed connection • Flash: Adobe Flash Player 9 or later
Copyright 2019. American Academy of CME, Inc., Beaumont Health, and American Conference for the Treatment of HIV.
- Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Available at: https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv/0
- The INSIGHT START Study Group. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med. 2015;373:795-807. Available at: https://aids.nlm.nih.gov/aidsinfo-guideline-course
- New York State AIDS Institute Online Resources for PrEP and nPEP. Available at: https://www.nejm.org/doi/full/10.1056/NEJMoa1506816
- Cofey S, et al. High Rates of Virologic Suppression After Rapid ART Start in a Safety-Net Clinic. CROI; March 4-7, 2019; Seattle, WA; Abstract 515. Available at: http://www.croiconference.org/sessions/high-rates-virologic-suppression-after-rapid-art-start-safety-net-clinic
- Key to HIV Drug Name Abbreviations. AIDSinfo. Available at: https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv/292/drug-name-abbreviations
- HIV Drug Interactions. University of Liverpool. Available at: https://www.hiv-druginteractions.org/checker
- AIDSinfo® HIV/AIDS Guidelines: E-Learning Course. Available at: https://aids.nlm.nih.gov/aidsinfo-guideline-course
- Saag MS, et al. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2018;320(4):379-396. Available at: https://jamanetwork.com/journals/jama/article-abstract/2688574